PCCA Ltd

What PCCA Ltd does

PCCA Ltd is a UK-licensed compounding pharmacy headquartered at Low Prudhoe Industrial Estate, Northumberland, that manufactures and supplies personalised medicines (also known as 'specials') for patients whose clinical needs are not met by licensed pharmaceuticals. Originally founded in 1999 as The Specials Laboratory, the company joined the global PCCA network in 2014 and operates as the UK arm of an international compounding group with offices in the United States, Australia and Canada. The business serves two principal customer groups: healthcare professionals (doctors, veterinarians, hospitals, clinics, pharmacies and referral centres, as well as government buyers such as the UK Ministry of Defence) who order specials directly, and individual patients who receive personalised medicines through private prescriptions fulfilled by PCCA's on-site GPhC-registered pharmacy and delivered via approved couriers.

The company's core technology is a portfolio of proprietary PCCA base formulations — including Lipoderm, Atrevis Hydrogel, Ellage Anhydrous Vaginal, ZoSil, SuspendIt, XemaTop, PracaSil-Plus and VersaBase Cream — that enable drug delivery in multiple dosage forms (topical gels and creams, oral liquids, capsules, lozenges, rapid dissolve tablets, transdermal and vaginal preparations, and veterinary formats). These bases, described as patented and supported by peer-reviewed publications, are combined with a large proprietary formula database to compound patient-specific medications. PCCA also markets a small set of branded licensed products (Arjun Cream, SodiClor Oral Solution, MagnaPhate Tablets) listed in the UK Drug Tariff, distributes cannabis-based medicines for mental health indications, and operates a specialist distribution business (storage, import/export, regulatory and QP services) for pharmaceutical companies under its MHRA WDA(H) and MIA(IMP) authorisations.

PCCA generates revenue through five streams: unlicensed specials manufacturing, private prescription and compounding services, outsourced specialist pharmaceutical distribution, branded Drug Tariff products, and cannabis-based medicines. Pricing is not publicly disclosed and customers obtain quotes on request. Distribution occurs through direct-to-patient courier delivery, direct-to-professional ordering, pharmacy and wholesale channels (with free same/next day delivery on regular wholesale orders), and global specialist distribution partnerships including exclusive UK arrangements with Iscador AG (mistletoe therapy) and Bracco UK (diagnostic imaging). The company's regulatory footprint — MHRA licences 17661 (Specials, MIA, ManSA veterinary, WDA(H), MIA(IMP), API Registration), GPhC registrations 9010218/9012165, and Controlled Drug Licence 1411 — constitutes a meaningful entry barrier and underpins the entire operating model.

Name

PCCA Ltd

Legal name

PCCA Limited

Website

https://pccarx.co.uk

Company type

Private

Founded year

1999

Operating status

Operating

Short description

PCCA Ltd is a UK-licensed compounding pharmacy that manufactures and supplies personalised unlicensed medicines (specials) using proprietary base technologies, serving healthcare professionals, veterinary practices, NHS/government buyers, pharmaceutical companies, and patients via private prescription.

Ownership category

akta.pro rank

Headquarters

HQ city

Prudhoe

HQ country

United Kingdom

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Specials Manufacturing: Manufacture and supply of unlicensed medicines (specials) to meet individual clinical needs of patients when suitable licensed medicines are not available. Includes all non-sterile dosage forms.
2. Prescription Services: Private prescription and compounding pharmacy services for personalised medicines. Patients receive customised medications prescribed by healthcare professionals.
3. Specialist Distribution: Outsourced distribution services for healthcare and pharmaceutical companies. Includes pharmaceutical storage, import/export, order fulfilment, regulatory and QP services, and market access support.
4. Arjun Products: Sale of branded pharmaceutical products including SodiClor Oral Solution, MagnaPhate Tablets, and Arjun Cream (menthol in aqueous cream). Listed in Drug Tariff.
5. Cannabis-Based Medicines: Supply of cannabis-based medicines for mental health conditions such as anxiety, depression and PTSD, prescribed by specialist prescribers on the GMC specialist register.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

PCCA Ltd is a UK compounding pharmacy that formulates and supplies personalised medicines (specials) and veterinary specials to meet individual patient clinical needs when licensed medicines are unsuitable. Using proprietary PCCA base technologies, the company prepares customised dosage forms including creams, gels, oral liquids, capsules, lozenges, rapid dissolve tablets and transdermal preparations, dispensed via its on-site GPhC-registered pharmacy, MHRA-licensed manufacturing facility and specialist distribution network.

Product overview

PCCA Ltd operates as a personalised medicine and compounding pharmacy with a comprehensive portfolio of products and services. The core offering centres on Specials Compounding - customised medications formulated to meet individual patient clinical needs when standard treatments are unsuitable - alongside Veterinary Specials for animal patients. The company provides proprietary PCCA Base Technologies (29 patented compounding bases) that enable various delivery systems including topical gels, oral suspensions, vaginal preparations, and transdermal applications. Additional products include Arjun branded pharmaceuticals (Arjun Cream, SodiClor Oral Solution, MagnaPhate Tablets), while services encompass Specialist Distribution, Formulation and Clinical Support, and Quality Assurance. The portfolio serves multiple therapeutic areas including women's health, men's health, pain management, dermatology, mental health, and veterinary medicine.

Differentiator

Problem solved

Functional benefit

Products and services

• Personalised Medicines / Specials Compounding Core service offering: customised medicines formulated to meet individual patient clinical needs when standard licensed treatments are unsuitable. Includes dosage customisation, combination therapies, allergen-free options and alternative delivery forms (creams, gels, oral liquids, capsules, lozenges, rapid dissolve tablets, transdermal). Fulfilled via private prescription through PCCA's MHRA-licensed manufacturing facility and GPhC-registered on-site pharmacy.
• Veterinary Specials
• Specialist Distribution Services
• Formulation and Clinical Support
• PCCA Base Technologies
• Arjun Cream
• SodiClor Oral Solution
• MagnaPhate Tablets

Quantifiable outcome

• Created over 1 million personalised medicines
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Two partnerships are on record, tiered core.

• Iscador AGcoreChannel Partner/ Reseller/ DistributorExclusive UK partner for the supply and distribution of Iscador AG's mistletoe therapy and mistletoe treatments. PCCA provides distribution across the UK for this complementary cancer therapy product.
• Bracco UKcoreChannel Partner/ Reseller/ DistributorPartnership with Bracco UK to provide diagnostic imaging solutions in the UK market.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Target Healthcare: UK manufacturer and distributor of unlicensed specials medicines to pharmacies, hospitals and prescribers; overlaps with PCCA on specials manufacturing, MHRA licensing and pharmacy/wholesale distribution.
• The Specials Company: UK-based specials manufacturer focused on unlicensed medicines for NHS and private prescriptions; closely comparable to PCCA on service scope, customer base and regulatory profile.
• Nova Laboratories: UK-based specialty pharmaceutical manufacturer offering bespoke and small-batch production including unlicensed medicines; comparable to PCCA on compounding, GMP manufacturing and licence-driven healthcare customer base.
• BCM Specials: UK-based specials manufacturer and compounding pharmacy serving NHS and private prescriptions with unlicensed medicines; directly comparable to PCCA Ltd on core service offering, customer base and MHRA/GPhC licensing model.
• Breckland Pharma: UK specials manufacturer producing unlicensed medicines and offering compounding services; directly comparable to PCCA on manufacturing model, regulatory licensing and prescriber-led demand channel.
• PharmaSpecials: UK-based unlicensed specials manufacturer supplying pharmacies and prescribers with bespoke preparations; directly comparable to PCCA on compounding, MHRA licensing and prescriber-channel distribution.
• East Anglian Pharma (Quantum Pharma): UK unlicensed specials manufacturer with MHRA licences serving hospitals, pharmacies and clinicians; directly comparable to PCCA on specials production, regulatory stack and prescriber-led commercial model.

Broad incumbents

• Medisca: Global pharmaceutical compounding supplier of APIs, vehicles and bases used by compounding pharmacies worldwide; a broader incumbent comparable to PCCA via its base technologies and pharmaceutical compounding focus, though not a direct UK pharmacy competitor.
• Fagron: Global leader in pharmaceutical compounding supplying APIs, bases and equipment to compounding pharmacies; serves as a broader incumbent whose compounding supplies and finished dosage offerings overlap with PCCA's base technology and specials business.
• B. Braun Melsungen (Compounding / CAPS): Global medical products company with a dedicated Central Admixture Pharmacy Services (CAPS) compounding arm serving hospitals; a broader incumbent whose outsourced sterile and non-sterile compounding business overlaps with PCCA's healthcare-professional-facing specials manufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pcca-uk

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PCCA Ltd